199 related articles for article (PubMed ID: 23409137)
1. Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.
Lan YY; Yeh TH; Lin WH; Wu SY; Lai HC; Chang FH; Takada K; Chang Y
PLoS One; 2013; 8(2):e56121. PubMed ID: 23409137
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.
Hsu M; Wu SY; Chang SS; Su IJ; Tsai CH; Lai SJ; Shiau AL; Takada K; Chang Y
J Virol; 2008 Apr; 82(7):3679-88. PubMed ID: 18234802
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytes.
Lee CH; Yeh TH; Lai HC; Wu SY; Su IJ; Takada K; Chang Y
J Virol; 2011 Jul; 85(14):7333-42. PubMed ID: 21543473
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.
Zhao M; Nanbo A; Becnel D; Qin Z; Morris GF; Li L; Lin Z
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847852
[TBL] [Abstract][Full Text] [Related]
8. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.
Lu J; Chen SY; Chua HH; Liu YS; Huang YT; Chang Y; Chen JY; Sheen TS; Tsai CH
J Virol; 2000 Aug; 74(16):7391-9. PubMed ID: 10906192
[TBL] [Abstract][Full Text] [Related]
10. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.
Lu J; Chua HH; Chen SY; Chen JY; Tsai CH
Cancer Res; 2003 Jan; 63(1):256-62. PubMed ID: 12517806
[TBL] [Abstract][Full Text] [Related]
11. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
Cox MA; Leahy J; Hardwick JM
J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
[TBL] [Abstract][Full Text] [Related]
12. Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.
Huang J; Liao G; Chen H; Wu FY; Hutt-Fletcher L; Hayward GS; Hayward SD
J Virol; 2006 Feb; 80(3):1098-109. PubMed ID: 16414987
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
16. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.
Chang Y; Lee HH; Chen YT; Lu J; Wu SY; Chen CW; Takada K; Tsai CH
J Virol; 2006 Aug; 80(15):7748-55. PubMed ID: 16840354
[TBL] [Abstract][Full Text] [Related]
17. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
18. Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.
Zhou Y; Heesom K; Osborn K; AlMohammed R; Sweet SM; Sinclair AJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694936
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
Kondo S; Wakisaka N; Schell MJ; Horikawa T; Sheen TS; Sato H; Furukawa M; Pagano JS; Yoshizaki T
Int J Cancer; 2005 Jun; 115(3):368-76. PubMed ID: 15688379
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.
Heather J; Flower K; Isaac S; Sinclair AJ
J Gen Virol; 2009 Jun; 90(Pt 6):1450-1454. PubMed ID: 19264650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
